Use access key #2 to skip to page content.
$45.80 1.67 (3.78%)
7/3/2008 1:00 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar OhioSt88 (< 20) Submitted: 5/10/07 11:33 AM : Outperform Start Price: $51.05 AZN Score: 5.73

Undervalued. Continuously reports strong earnings and is developing and buying a pipeline with innovation.

Report this Post Replies: 0 | Reply

Featured Broker Partners